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The manufacturing of clinically relevant cells is a widely used strategy in regenerative medicine.
Cahan et al. develop a network biology platform named CellNet to accurately assess the fidelity
of such cells and spot aberrant regulatory networks, andMorris et al. apply this platform to improve
cell manufacturing.Proper lineage commitment and cell fate
determination are crucial to ensuring
appropriate development. Specifically,
gene regulatory networks (GRNs) control
the dynamic spatial and temporal pat-
terns of regulatory gene expression dur-
ing development (Davidson, 2010). Cells
in the organism receive all the signals
required to attain the highest level of func-
tionality. Despite many years of research,
the underlying basis for full cell function-
ality in vivo remains elusive. In essence,
we fail to understand why a given cell—
regardless of whether it is derived
by directed differentiation of stem cells
or by direct conversion from somatic
cells—does not faithfully recapitulate the
in vivo cell properties when manufactured
in vitro (Jopling et al., 2011). This draw-
back can be overcome only by garnering
a better understanding of cell similarity
and unraveling the pathways for improv-
ing the sameness and, consequently,
functionality of the manufactured cells.
In the current issue of Cell, two studies
by the groups of James Collins and
George Daley (Cahan et al., 2014; Morris
et al., 2014) introduce a novel network
biology platform, named CellNet. This
platform compares the GRNs of cells
manufactured in vitro with those of their
in vivo counterparts and attributes a score
to them.
Cahan et al. (2014) report that cells
differentiated from embryonic stem cells
(ESCs) have higher scores than directly
converted cells, although the differenti-
ated cells differ from their in vivo counter-
parts (Figure 1A). One reason for this
difference is that the desired tissue-
and cell-type GRNs are incompletely or
improperly established. Promoter inac-cessibility is likely the major barrier.
Developing strategies that augment the
opening of closed chromatin may enable
complete establishment of the desired
tissue- and cell-type GRN status. The
difference could also be attributed to
the presence of residual ESC GRNs. The
residual GRNs in ESC-differentiated cells
are closely associatedwith ESCcell-cycle
regulation, which may engender the
resultant cells with tumorigenic potential.
This is particularly problematic, as the
resultant cells could be of clinical rele-
vance. Thus, meticulous inspection is
required to ensure the differentiated
cells are free of ESC GRNs. CellNet can
serve as a rigorous inspector in this
regard. Finally, unexpected generation of
different cell-type-specific GRNs during
differentiation is yet another reason.
Cells directly converted from fibro-
blasts have lower classification scores,
as the desired tissue- and cell-type
GRNs are incompletely established (Fig-
ure 1B). This is associated with a high
residual fibroblast GRN status of the
resultant cells and unwanted GRNs
established during the direct conver-
sion process. Although cells directly
converted might mimic gene expression
patterns of their in vivo counterparts,
numerous genes are differentially ex-
pressed (Caiazzo et al., 2011; Sekiya
and Suzuki, 2011; Yu et al., 2013). Two
aspects of their heat map analysis reflect
the cell-type-specific memory of the
starting cells and an exogenous factor-
mediated off-target effect (Caiazzo et al.,
2011; Sekiya and Suzuki, 2011; Yu et al.,
2013). The first aspect is that (1) genes
are inactive in both the starting and
resultant cells but highly expressed inCell 15the in vivo counterparts, and (2) genes
are highly expressed in both the starting
and resultant cells but inactive in the
in vivo counterparts. Consistent with
these findings, CellNet convincingly
detected considerably higher donor cell
GRNs in the resultant cells. The second
aspect is that genes are expressed in
the resultant cells, which had not been
active in the in vivo counterparts and
starting cells. Such a scenario is possible
if the factors used in the conversion can
actually turn on different cell-type-spe-
cific GRNs. As CellNet accurately detects
unexpected GRNs from converted cells,
one could go back and address such
problems. An important lesson here is
that a minimal set of transcription factors
employed in the direct conversion pro-
cess might be insufficient for faithfully
recapitulating the properties of the in vivo
counterparts in the resultant cells.
So far, direct conversion of fibroblasts
into cells faithfully recapitulating the
properties of in vivo counterparts has
proven difficult. Morris et al. (2014)
attempt to alleviate this difficulty using
CellNet. They first identify that macro-
phages directly converted exhibit a high
B cell GRN, with only a partial macro-
phage identity (Figure 1D). Knockdown
of Pou2af1 and Ebf1 in macrophages,
as suggested by CellNet, significantly
improves the cells’ similarity and function-
ality. However, B-cell-specific GRNs
still remain intact after knockdown. The
authors also used the so-called induced
hepatocytes (iHeps) as another model
(Figure 1E). CellNet analysis of iHeps
identifies both liver and intestine GRNs.
The coexistence of the two cell fates in
one cell type suggests that the functional8, August 14, 2014 ª2014 Elsevier Inc. 699
Figure 1. The CellNet Platform Assesses the Fidelity of the Resultant Cells from Direct
Differentiation and Direct Conversion
(A) In vitro direct differentiation of embryonic stem cells (ESCs). The resultant cells have incompletely
established their in vivo counterpart GRNs (orange). Residual ESC GRNs are incompletely silenced (blue).
Unexpected GRNs are partially or transiently established (black).
(B) In vitro direct conversion by ectopic expression of lineage-specific transcription factors. The resultant
cells exhibit persistently high donor-cell-specific GRN status (blue). Their in vivo counterparts GRNs are
partially established (orange). Unintended GRNs unexpectedly emerge during direct conversion (black).
(C) In vivo direct conversion by ectopic expression of lineage-specific transcription factors. The resultant
cells exhibit complete establishment of in vivo counterparts GRNs (orange). The donor-cell-specific GRNs
are completely silenced.
(D) Direct conversion of B cells into macrophages by ectopic expression of C/EBPa. The resultant cells
exhibit incomplete establishment of macrophage-specific GRNs (light orange). Residual B-cell-specific
GRNs remained active (blue). Hematopoietic stem cell (HSC)-specific GRNs are partially established
(black). Knockdown of Ebf1 and Pou2af1 in macrophages improvesmacrophage identity and functionality
(orange). However, donor-cell-specific GRNs remain intact (blue). The intensity of the orange color reflects
the fidelity of the resultant cell identity.
(E) Direct conversion of fibroblasts into endoderm-progenitor-like cells (iEPs) and hepatocyte-like cells
(iHeps). Higher levels of Hnf4a and Foxa1 drive the cells toward iEPs, which have both intestinal (orange)
and hepatic (black) fates. Lower levels of Hnf4a and Foxa1 promote conversion into cells of the hepatic
fate. Knockdown of Cdx2 in iEPs allows for transition of the cells toward iHeps. Klf4 and Klf5 need to be
overexpressed in iEPs for achieving mature intestinal cells in vitro. Donor-cell-specific GRNs remain
intact (blue). iEPs can differentiate into cells resembling colonic epithelium in vivo after they are trans-
planted into the colon. Donor-cell-specific GRNs are almost extinguished in engrafted cells.
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pressed by another. Indeed, knockdown
of CellNet-prioritized Cdx2, a regulator
of the intestinal fate in iHeps, fortifies the
cells’ liver similarity and functionality.
However, neither liver classification nor
liver GRN status is improved following
knockdown.
CellNet efficiently selects candidate
factors, and their manipulation in the cells
somewhat enhances their similarity and
functionality. However, donor-cell-spe-
cific GRNs appear to be tightly locked
and can hardly be extinguished (Figure 1).
Furthermore, partial classification scores
and unsatisfactory GRN status are almost
never improved. These phenomena do
not occur in two instances—in the direct
conversion in vivo of cardiac fibroblasts
into cardiomyocytes (Cahan et al., 2014),
and in the differentiation in vivo of iHeps/
iEPs into cells resembling colonic epithe-
lium after transplantation into the colon
(Morris et al., 2014). Conversion could,
therefore, be improved by using the
instructive signals of the endogenous
cell niche. An important task is to define
in vitro conditions that closely resemble
such instructive signals, so cells can be
derived that faithfully recapitulate the
properties of in vivo counterparts.
To date, the cells directly converted
from fibroblasts by ectopic expression of
Hnf4a and Foxa1 have been considered
to be iHeps (Sekiya and Suzuki, 2011).
A surprising finding of the study by
Morris et al. (2014) is that iHeps actually
appear to be endoderm progenitors (iEPs)
(Figure 1E). They have the capacity to
differentiate in vitro into either mature
hepatocyte-like cells, if Cdx2 is depleted,
or intestine-like cells, if the CellNet-priori-
tized factors Klf4 and Klf5 are overex-
pressed. Mature cells resembling colonic
epithelium are also generated when iEPs
are transplanted into the colon—even
without Klf4 and Klf5. Furthermore, Cell-
Net, along with other analyses, reveals
that cells possessing mature hepatocyte
properties can be generated from fibro-
blasts if low levels of Hnf4b and Foxa1 are
supplied. Now, it would be interesting
to compare the GRNs of iEPs to those of
other iHeps generated by different tran-
scription factors (Vallier, 2014) or to those
of the bipotential hepatic stem cells gene-
rated from fibroblasts by transduction
with Hnf1a and Foxa3 (Yu et al., 2013).
According to Cahan et al. (2014), re-
programming somatic cells into induced
pluripotent stem cells (iPSCs) is the
most complete and successful pluripo-
tency manufacturing procedure. Indeed,
the GRNs of iPSCs and ESCs are essen-
tially indistinguishable. Reprogramming
success apparently depends on a well-
established protocol with a combina-
tion of well-defined transcription factors,
culture conditions, and selection makers.
The resultant iPSCs comprise a homo-
geneous population with a high clonality,
as a single cell readily expands into an
individual clone. Furthermore, current
culture conditions, for example 2i, sup-
port the growth of only undifferentiated
cells. The question remains how well
reprogrammed cells correspond to the
in vivo counterparts, namely the inner
cell mass (ICM) of blastocysts. They
might not correspond, because the
culture conditions during the repro-
gramming process determine whether
the cells eventually acquire a naive or
a primed pluripotent state (Han et al.,
2011). Moreover, a recent description
of abnormalities in human pluripotent
cells generated by reprogramming (Ma
et al., 2014) suggests that there is con-siderable room for improvement in this
field as well.
Taken together, the two studies dis-
cussed here have established that
assessment of the fidelity of in-vitro-
manufactured cells and improvement of
their quality using CellNet is feasible.
This achievement marks a compelling
step forward in the production of rele-
vant cells for regenerative medicine.
However, several points remain to be
addressed. CellNet cannot distinguish
between distinct cell subtypes, as it
operates largely based on bulk tissues.
Cells cultured in vitro often exhibit
specific characteristics imposed upon
them by their culture environment (Han
et al., 2011), whereas the majority of
the training data in CellNet is generated
from in vivo tissues. Those factors may
increase false-positive rates and in turn
lead to inaccurate conclusions. Employ-
ing single-cell RNA sequencing data
from distinct cell types that have been
actively cultured in vitro may resolve
the issues. Future studies should aim
to transfer this technology to cells
from patients with genetically inherited
disorders for screening aberrant net-
works and finding ways to correctCell 15these networks by means of genetic
manipulation.
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Photosystem II uses metal ions to oxidize water to form O2. Two recent papers employ the new
technique of serial femtosecond crystallography utilizing X-ray free-electron lasers and nanocrys-
tals to obtain initial structures of intermediate states of photosystem II catalysis at the site of oxygen
production.Walking through the green of summer
should remind us of the unseen molecular
machinery that plants, algae, and cyano-
bacteria use to harness light for the con-
version of water and carbon dioxide into
sugars and oxygen. Photosynthesis main-tains Earth’s oxygen levels and provides
the basis of our food chain (Blankenship,
2014). Membrane-bound multiprotein
complexes, photosystems I and II, cata-
lyze the light-driven reactions at the heart
of this process. Two recent articles use se-rial femtosecond crystallography to cap-
ture time-resolved snapshots of changes
in the oxygen-evolving center of photo-
system II (Kern et al., 2014; Kupitz et al.,
2014). These studies not only provide
insight into structural events occurring8, August 14, 2014 ª2014 Elsevier Inc. 701
